AIC
ICPT

Ameritas Investment Company’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Ameritas Investment Company’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$6K – 1693
2020
Q1 		$6K Buy
+100
New +$8.99K ﹤0.01% 1358
2019
Q1 		– Sell
-450
Closed -$45K – 1867
2018
Q4 		$45K Buy
+450
New +$46.6K 0.01% 613

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Ameritas Investment Company's ICPT Position: Q2 2020 in Review

Ameritas Investment Company sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 100 shares — an estimated $6K sold.

Ameritas Investment Company first reported a position in ICPT in Q4 2018 and held it in 2 quarters. The position peaked at $45K in Q4 2018. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

  • Ameritas Investment Company reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Company sold 100 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $6K.
  • Ameritas Investment Company first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
  • Ameritas Investment Company's Intercept Pharmaceuticals, Inc. position peaked at $45K in Q4 2018.
  • 192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.